Global Analysis of Smad2/3-Dependent TGF-β Signaling in Living Mice Reveals Prominent Tissue-Specific Responses to Injury1

Smad2 and Smad3 (Smad2/3) proteins are key signaling molecules for TGF-β and some related family members regulating the transcription of several hundred genes. TGF-β have key roles in development, tissue homeostasis, and the pathogenesis of many human diseases, including cancer, fibrotic disorders, developmental defects, and neurodegeneration. To study the temporal and spatial patterns of Smad2/3-dependent signaling in normal and pathological conditions in the living organism, we engineered transgenic mice with a Smad-responsive luciferase reporter construct (SBE-luc mice). Using bioluminescent imaging, we assessed Smad2/3 signaling activity noninvasively in living mice. At baseline, this activity was highest in brain, intestine, heart, and skin, and correlated with biochemical measurements of reporter activity. Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-β family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine. Although the response was similarly rapid in brain, it remained increased, indicating important but different cellular responses to endotoxin challenge in these organs. Traumatic brain injury with a needle stab resulted in local activation of Smad2/3-dependent genes and a severalfold increase in bioluminescence in living mice. SBE-luc mice can therefore be used to study temporal, tissue-specific activation of Smad2/3-dependent signaling in living mice in normal or pathological conditions as well as for the identification of endogenous or synthetic modulators of this pathway.

[1]  Anita B. Roberts,et al.  Expression of transforming growth factor-β2 and β3 mRNAs and proteins in the developing chicken embryo , 1994 .

[2]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[3]  G. Krystal,et al.  LPS-induced upregulation of SHIP is essential for endotoxin tolerance. , 2004, Immunity.

[4]  P. Carvey,et al.  Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain , 2004, Neuroscience.

[5]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[6]  M. Recce,et al.  Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss. , 2001, Physiological genomics.

[7]  D. Morgan,et al.  Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice , 2004, Experimental Neurology.

[8]  Hans Clevers,et al.  Signaling pathways in intestinal development and cancer. , 2004, Annual review of cell and developmental biology.

[9]  C. Contag,et al.  Advances in in vivo bioluminescence imaging of gene expression. , 2002, Annual review of biomedical engineering.

[10]  F. Moore.  The role of the gastrointestinal tract in postinjury multiple organ failure. , 1999, American journal of surgery.

[11]  J. Wrana,et al.  Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.

[12]  八木 健,et al.  Alternatively spliced variant of smad2 lacking exon 3 : comparison with wild-type smad2 and smad3 , 2001 .

[13]  M. Goumans,et al.  Distribution of phosphorylated Smad2 identifies target tissues of TGF beta ligands in mouse development. , 2003, Gene expression patterns : GEP.

[14]  B. O’Malley,et al.  Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Subhabrata Sanyal,et al.  Retrograde Regulation in the CNS Neuron-Specific Interpretations of TGF-β Signaling , 2004, Neuron.

[16]  K. Flanders,et al.  TRANSFORMING GROWTH FACTOR-βS IN NEURODEGENERATIVE DISEASE , 1998, Progress in Neurobiology.

[17]  R. Kucherlapati,et al.  Hierarchical model of gene regulation by transforming growth factor β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Mucke,et al.  Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Wahl,et al.  TGF‐β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells , 2004, Journal of leukocyte biology.

[20]  H. Carlsen,et al.  In Vivo Imaging of NF-κB Activity1 , 2002, The Journal of Immunology.

[21]  A. Brivanlou,et al.  The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. , 2001, Genes & development.

[22]  C. Klein,et al.  Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. , 2004, Molecular endocrinology.

[23]  K. Flanders,et al.  Characterization of the mouse Smad1 gene and its expression pattern in adult mouse tissues. , 2000, Gene.

[24]  J. Massagué,et al.  TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.

[25]  M. Goumans,et al.  Transforming growth factor β signal transduction , 2002, Journal of leukocyte biology.

[26]  S. P. Oh,et al.  Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. , 2002, Genes & development.

[27]  E. Masliah,et al.  Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.

[28]  Chad H. Koonce,et al.  Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile. , 2005, Genes & development.

[29]  T. Wyss-Coray,et al.  Modelling neuroinflammatory phenotypes in vivo , 2004 .

[30]  Edward S. Kim,et al.  Immunohistochemical expression of smads 1–6 in the 15‐day gestation mouse embryo: signaling by BMPs and TGF‐βs † , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[31]  L. Mucke,et al.  Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. , 1995, The American journal of pathology.

[32]  C. Mummery,et al.  Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins , 2004, Journal of Cell Science.

[33]  T. Macdonald,et al.  Immunity, Inflammation, and Allergy in the Gut , 2005, Science.

[34]  L. Mucke,et al.  TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice , 2001, Nature Medicine.

[35]  E. Jansen,et al.  Selective IκB Kinase Expression in Airway Epithelium Generates Neutrophilic Lung Inflammation1 , 2003, The Journal of Immunology.

[36]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[37]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[38]  K. Miyazono,et al.  Characterization of a bone morphogenetic protein-responsive Smad-binding element. , 2000, Molecular biology of the cell.

[39]  V. Perry,et al.  Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.